Login to Your Account



Aventis Pasteur Files For Approval Of Long-Acting Meningitis Vaccine

By Kim Coghill


Monday, December 29, 2003
Aventis Pasteur filed a biologics license application for Menactra, a conjugate vaccine believed to provide protection against meningococcal meningitis for a longer period than the company's currently marketed product. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription